Updates

Categories
  1. Esophageal cancer

    Pembrolizumab showed positive results in heavily pretreated, PD-L1–positive advanced esophageal carcinoma.
    Industry news

    Read more »
  2. Melanoma

    Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma.
    Industry news

    Read more »
  3. Lung cancer

    Eight important updates in lung cancer.
    Industry news

    Read more »
  4. Promising Developments in Treatment of Multiple Myeloma!

    Darzalex (daratumumab) combination under review as first-line option.

    Multiple Myeloma

    Read more »
  5. HIV/AIDS

    Immunotherapy nivolumab has been linked to HIV reservoir decrease in a lung cancer patient. 
    Industry news

    Read more »
  6. Breast cancer

    In a pilot study immunotherapy proved active in some patients with metastatic, trastuzumab (Herceptin)-resistant HER2-positive breast cancer.
    Industry news

    Read more »
  7. Lung cancer

    Researchers are suggesting that metastatic tumours in the lung can be successfully eradicated using cryotherapy – literally turning the masses into ice balls that are then resorbed by the body.
    Industry news

    Read more »
  8. Multiple Sclerosis

    Mavenclad (cladribine) has become the multiple sclerosis therapy of choice for 1 in 5 neurologists in Germany and the UK. Meanwhile, many European neurologists wait for Ocrevus (ocrelizumab).
    Industry news

    Read more »
  9. PrEP for HIV Prevention

    With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

    PrEP for HIV Prevention

    Read more »
  10. Another high price tag for Duchenne muscular dystrophy treatment

    PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.

    Read more »
  11. Jimmy Carter’s cancer remission highlights the power of pembrolizumab

    On Sunday former US president and Nobel Peace Prize laureate proclaimed to a Sunday school class that he is cancer-free.

    Jimmy Carter cancer

    Read more »
  12. Promising results for cancer-immunotherapies revealed!

    Impressive results have been published last week regarding two new immunotherapies. 

    Lab Image

    Read more »
Page